Herbas VPB

Print
EN | LT
LT - ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES
EN - ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 38/2086 (2013.01)
C07K 16/18 (2006.01)
C07K2319/30 (2013.01)
C07K 14/54 (2006.01)
C07K 16/2863 (2013.01)
C07K 14/715 (2006.01)
A61K2039/505 (2013.01)
A61K 38/20 (2006.01)
C07K2317/732 (2013.01)
A61K 38/19 (2006.01)
A61P 37/06 (2018.01)
A61K 38/17 (2006.01)
A61P 35/00 (2018.01)
A61K 39/395 (2006.01)
C07K 14/5443 (2013.01)
A61P 35/00 (2006.01)
C07K 14/7155 (2013.01)
A61P 37/06 (2006.01)
C07K 16/2896 (2013.01)
European patent
(11) Number of the document 3601363
(13) Kind of document T
(96) European patent application number 18776459.2
Date of filing the European patent application 2018-03-30
(97) Date of publication of the European application 2020-02-05
(45) Date of publication and mention of the grant of the patent 2022-06-15
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2018/025366
Date 2018-03-30
PCT application publication
(87) Number WO 2018/183821
Date 2018-10-04
Priority applications
(30) Number Date Country code
201762480339 P 2017-03-31 US
201815937493 2018-03-27 US
Inventors
(72)
SHRESTHA, Niraj , US
LIU, Bai , US
RHODE, Peter , US
WONG, Hing, C. , US
Grantee
(73) Altor BioScience Corporation , 2810 North Commerce Parkway, Miramar, Florida 33025, US
Title
(54) ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES
  ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES